Isifo sikaPeyronie
Isifo sikaPeyronie yisifo esixhuma izicubu esihilela ukukhula kwamapuleti anemicu ezicutshini ezithambile zepipi .Ngokukhethekile, amafomu wesicubu esibomvu ku-tunica albuginea, umgogodla wesicubu ozungeze i- corpora cavernosa, obangela ubuhlungu, ukugobeka okungavamile, ukungasebenzi kahle kwe-erectile, ukuqaqanjelwa, ukulahlekelwa yibhande kanye nokunciphisa. [1]
Kulinganiselwa ukuthi kuthinta cishe amadoda ayi-10%.Isimo siba ngokuvame kakhulu ngeminyaka.
Izimpawu nezimpawu
[hlela | Hlela umthombo]Izinga elithile lokugobeka lobudoda lithathwa njengelivamile, njengoba amadoda amaningi ezalwa enalesi simo sobungozi, esivame ukubizwa ngokuthi ukugobeka kokuzalwa.Lesi sifo singadala ubuhlungu; izilonda eziqinile, ezinkulu, ezifana nentambo (izicubu ezibomvu ezaziwa ngokuthi "amapuleti"); noma ukugobeka kwendoda ngokungajwayelekile lapho imile ngenxa yokuvuvukala okungapheli kwe- tunica albuginea (CITA).
Izimbangela
[hlela | Hlela umthombo]Imbangela yesifo sikaPeyronie ayaziwa.Noma kunjalo, kungenzeka ukuthi kungenxa yokwakheka kocwecwe ngaphakathi kwepenisi ngenxa yokuhlukumezeka okuphindaphindayo noma ukulimala ngesikhathi sokuya ocansini noma komzimba. [2]
Izici ezinobungozi zibandakanya isifo sikashukela, isivumelwano sikaDupuytren, i- plantar fibromatosis, ukuhlukunyezwa kwe-penile, ukubhema, ukuphuza ngokweqile , ukuthambekela kofuzo, kanye nefa laseYurophu. [3] [4]
Ukuxilongwa
[hlela | Hlela umthombo]Udokotela we-urologist angakwazi ukuxilonga lesi sifo futhi asikisele ukwelashwa.I-ultrasound inganikeza ubufakazi obuqand 'ikhanda besifo sikaPeyronie, esinquma ukuphuma kwesisu noma okunye ukuphazamiseka. [5]
-
Transverse ultrasound of the penis, in a ventral view, in the middle portion of the penis. Note the echoic image with posterior acoustic shadowing, corresponding to calcification (arrow), in the left corpus cavernosum.[6]
-
Projectional radiography ("X-ray"), penetrating the soft parts of the penis, showing radiopaque images that correspond to calcifications in the corpora cavernosa (arrows).]]
Ukwelashwa
[hlela | Hlela umthombo]Imithi nezithasiselo
[hlela | Hlela umthombo]Izindlela eziningi zokwelapha ngomlomo sezifundwe kepha imiphumela kuze kube manje ixutshiwe. [7]Abanye babheka ukusetshenziswa kwezindlela ezingezona ezokuhlinzwa njengokuphikisana ". [8]
Ukwengezwa kukaVitamin E sekufundwe amashumi eminyaka, futhi impumelelo ethile ibikiwe ezivivinyweni ezindala kepha leyo mpumelelo ayiphindwanga ngokuthembekile ezifundweni ezinkulu, ezintsha. [9]
Ukusetshenziswa kwe- Interferon-alpha-2b ezigabeni zokuqala zalesi sifo sekufundwe kepha kusukela ngo-2007 ukusebenza kwaso bekungabazeka. [10]
I-Collagenase clostridium histolyticum kubikwa ukuthi izosiza ngokudiliza i-collagen eyeqile kupipi.Kwavunyelwa ukwelashwa kwesifo sikaPeyronie yi-FDA ngo-2013.
Ukwelashwa ngokomzimba namadivayisi
[hlela | Hlela umthombo]Kunobufakazi obulinganiselayo bokuthi i-penile traction therapy iyindlela ebekezeleleke kahle, yokwelashwa okuhlasela kancane, kepha kunokungaqiniseki ngobude besikhathi sokululeka ngosuku nangendlela yokwelashwa, futhi inkambo yokwelashwa inzima. [11]
Ukwelashwa Kwe-Shockwave Okugxile
[hlela | Hlela umthombo]Ukwelashwa okugxilwe ngaphandle kwe-shockwave kuyindlela yokwelashwa engeyona ehlaselayo ebandakanya ukudlulisa izingqimba ze-acoustic nge-plaque, ezingayidiliza ngaphezulu kwezikhathi eziyisithupha kuya kweziyishumi nambili. [12] [13]Ukwelashwa kusebenza kakhulu emadodeni anamaPeyronie amancane.
Ukuhlinzwa
[hlela | Hlela umthombo]Ukuhlinzwa, okufana "nokusebenza kweNesbit" (okuqanjwe ngoReed M. Nesbit (1898-1979), udokotela wase-American urologist e- University of Michigan ), [2] kuthathwa njengesixazululo sokugcina futhi kufanele kwenziwe kuphela ngomchamo onekhono kakhulu odokotela abahlinzayo abanolwazi ngamasu akhethekile wokuhlinza okulungisa.Ukufakwa kwe-penile kungahle kufaneleke ezimweni ezisezingeni eliphakeme. [14]
I-Epidemiology
[hlela | Hlela umthombo]Kulinganiselwa ukuthi kuthinta cishe amadoda ayi-10%.Isimo siba ngokuvame kakhulu ngeminyaka. [15]Iminyaka yobudala ekuqaleni kwesifo yiminyaka engama-55-60. [2]
Umlando
[hlela | Hlela umthombo]Isimo sichazwe okokuqala ngo-1561 ngokuxhumana phakathi kuka- Andreas Vesalius noGabriele Falloppio ngokuhlukile nguGabriele Falloppio.Lesi simo sibizwa ngoFrançois Gigot de la Peyronie, owasichaza ngo-1743.
Izinkomba
[hlela | Hlela umthombo]- ↑ "Peyronie's disease and erectile dysfunction: Current understanding and future direction". Indian Journal of Urology 22 (3): 246–50. doi:10.4103/0970-1591.27633.
- ↑ 2.0 2.1 2.2 The management of Peyronie's disease. January 2004.Ralph, D. J.; Minhas, S. (January 2004). Cite error: Invalid
<ref>
tag; name "pmid14690485" defined multiple times with different content - ↑ Hatzimouratidisa, Konstantinos; Eardley, Ian (2012). "EAU guidelines on penile curvature". European Urology 62 (3): 543–552. doi:10.1016/j.eururo.2012.05.040. PMID 22658761.
- ↑ Abern, Michael R.; Levine, Laurence A. (2009). "Peyronie's disease: evaluation and review of nonsurgical therapy". The Scientific World Journal 27 (9): 665–675. doi:10.1100/tsw.2009.92. PMID 19649505.
- ↑ Colour Doppler and duplex ultrasound assessment of Peyronie's disease in impotent men. May 1993.
- ↑ Cite error: Invalid
<ref>
tag; no text was provided for refs namedFernandesSouza2018
- ↑ Levine LA (October 2003). Review of current nonsurgical management of Peyronie's disease.
- ↑ A critical analysis of nonsurgical treatment of Peyronie's disease. June 2006.
- ↑ Oral therapy for Peyronie's disease. October 2002.
- ↑ Pharmacological Management of Peyronie's Disease.
- ↑ "Penile traction therapy and Peyronie's disease: a state of art review of the current literature". Ther Adv Urol. 5 (2): 59–65. February 2013. doi:10.1177/1756287212454932. PMC 3547530. PMID 23372611. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3547530.
- ↑ https://www.nice.org.uk/guidance/ipg29/documents/overview-of-extracorporeal-shockwave-therapy-for-peyronies-disease2
- ↑ https://edclinics.co.uk/peyronies-disease/
- ↑ "Surgical approaches for advanced Peyronie's disease patients". International Journal of Impotence Research 15 (Suppl 5): S121–4. October 2003. doi:10.1038/sj.ijir.3901085. PMID 14551588.
- ↑ Empty citation (help)